ICOSLG and melanoma: In turn, the expression of the CAR receptor was low in both the cell lines (4.4% and 4.0%, respectively for MUG Mel-1 and MUG Mel-2), thus supporting the rationale for the treatment of melanoma using oncolytic vector AdV-D24-ICOSL-CD40L [49].